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ABSTRACT

A mathematical model for the healing response of diabetic foot ulcers was
developed using averaged data (Krishna et al., 2015). The model contains four major
factors in the healing of wounds using four separate differential equations with 12
parameters. The four differential equations describe the interactions between matrix
metalloproteinases (MMP-1), tissue inhibitors of matrix metalloproteinases (TIMP-1), the
extracellular matrix (ECM) of the skin, and the fibroblasts, which produce these proteins.
Recently, our research group obtained the individual patient data that comprised the
averaged data. The research group has since taken several approaches to analyze the
model with the individual patient data. One approach was to introduce mixed modeling
techniques on certain parameters in that model. Mixed effects modeling is an analytical
tool useful for the repeated measurement of data with subjects, patients, etc., that have
random affects that deviate from a specified norm. This is accomplished by taking a
parameter that is shared across all data sets and splitting it into a fixed variable and a
random variable. Then all data sets are modeled so that the fixed variable is the same for
all patients and the random variable is a unique modifier that accounts for the differences
across patients. Another approach has been to use an optimal design technique to
identify which times are ideal for data gathering for the model. For this project a
Standard Error (SE) optimal design method was chosen with the goal of minimizing the
sum of squared normalized standard errors. Our project worked to combine these
techniques by first introducing mixed modeling parameter values into an SE-optimal
design algorithm and then comparing the results collected to the standard algorithm.
ii

Other optimal design techniques were used with and without these mixed modeling
parameters to see if a certain technique was better than the others. Finally, we worked
toward improving our estimates for mixed modeling parameters by attempting to
implement in MONOLIX. Our focus for this part was to develop test cases that could be
implemented in MONOLIX.
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INTRODUCTION

The wound-healing process is complex and requires the proper combination of
biological healing factors to be present in the correct ratios for the healing process to
progress. Proper healing occurs in four distinct stages: coagulation and hemostasis,
inflammation, proliferation, and wound remodeling (Velnar et al., 2009). Coagulation
and hemostasis begin the instant a wound is formed with the primary function being to
create a blood clot to prevent extreme blood loss that could lead to further heal risks. For
this to occur, an interconnected matrix of cells must be created which is permeable
enough to allow cells through that are needed for future healing while also preventing
excessive bleeding and further damage. This process begins immediately after trauma by
causing an involuntary reaction from the neuronal reflex that leads to the contraction of
blood vessels and vascular smooth muscle cells in the muscle layer. After this
constriction is ended, “blood spills into the site of injury, the blood components and
platelets come in contact with exposed collagen and other extracellular matrix
components” (Velnar et al., 2009). This creates a blood clot that is composed of
fibronectin, fibrin, vitronectin, and thrombospondin. These platelet clots contain a series
of growth factors that are important for later stages of the healing process. Without these
clots, platelet derived growth factor (PDGF), transforming growth factor-β (TGF- β),
epidermal growth factor (EGF), and insulin-like growth factor (IGF-1) would not be
present in the healing site. These promote the healing process by recruiting additional
healing factors into the site and activating them to begin the process of healing. In
addition to the introduction of growth factors, platelet clots also contain vasoactive
1

amines that are stored and lead to “fluid extravasation in the tissue that results in oedema,
which, in turn, potentiates itself during the following inflammation phase” (Velnar et al.,
2009).As coagulation and hemostasis nears completion, the inflammatory phase begins.
The goal of this phase is to purge any outside bacteria or infection-causing agents that
have entered the body during or after the formation of the wound. In the early stages of
inflammation, neutrophils enter and remove any of the outside bacteria that may cause
infection or hinder the healing process. The neutrophils enter the wound site around 2436 hours after a wound has formed. The neutrophils stick to the capillaries surrounding
the wound and use the flow of blood to move around the wound site gathering up bacteria
and any dangerous materials that have entered into the site. Once the site has been
cleared the neutrophils are purged and are replaced by macrophages that continue the
cleansing of the site. Macrophages have a longer lifespan than the fast acting neutrophils
and can work at lower pH levels as the wound healing progresses. As the healing process
continues, macrophages continue to clean the site as well as release growth factors that
recruit cells like fibroblasts, keratinocytes, and endothelial cells. These cells are so
important to the healing process that the lack of macrophages in the wound site “…
causes severe healing disturbances due to poor wound debridement, delayed fibroblast
proliferation and maturation, as well as delayed angiogenesis, resulting in inadequate
fibrosis and a more weakly repaired wound” (Velnar et al., 2009). Finally, the last step in
the inflammation stage is the entrance of lymphocytes and immunoglobulin G (IgG)
breakdown products that are crucial for later healing.
Once the inflammation phase has begun to subside and the wound site has been
thoroughly “cleaned” by neutrophils and macrophages, proliferation begins. This begins
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the tissue repair stages of wound healing. This stage begins with what is known as a
“fibroblast migration” to the wound site that essentially floods the wound site with
fibroblasts and myofibroblasts that are going to be in charge of synthesizing new
extracellular matrix in the wound (Velnar et al., 2009). These fibroblasts produce
collagen, which is vital for all stages of the healing process as it is the main structural
protein in the skin as well as in other tissues. While the production of the extracellular
matrix is obviously the main priority during this stage, blood vessels and other supportive
tissue is also developed and controlled by cell migration to the growth factors that have
been brought to the site during the inflammation phase. This ensures that any new
extracellular matrix that is created will have adequate numbers of capillaries and blood
flow present for continued health and re-growth. Endothelial cells are then “moved” into
place creating the matrix using three processes that work together: protrusion, adhesion,
and traction. Protrusion refers to filaments that “protrude” from the cell allowing for
cell-cell movement along the extracellular matrix. These filaments act as a sort of anchor
point for the cell and allow strong connections that can be manipulated to provide
movement. Adhesion is controlled by integrin, extracellular receptors that allow for the
adhesion between two cells, which are present in all cells in the extracellular matrix. The
proper regulation of adhesion is vital to the movement of these cells to the correct place
in the matrix for optimal migration rates that ebb and flow during the healing process
adhesion is vital. If there is not adequate cell adhesion, then the site will be flooded with
too many cells and healing is hindered. At the same time, if cells adhere too much to one
another, then endothelial cells struggle to get to the site, which delays or even stops the
healing process. Finally, traction is the pulling motion that is created between cells
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through their integrin connections. This pulling is what actually facilitates cell
movement, which is controlled by the adhesion of the cell and is made possible because
of the protrusion from the cell. Without proper protrusion and cell adhesion, wound
healing is hindered. When these three processes work together properly, endothelial cells
are transported to the wound site and production of the extracellular matrix continues.
In the remodeling phase of the process, scar tissue and epithelium, the thin outside
layer of the skin, are produced to complete healing of the wound. This process is actually
begun quite soon after injury and can take up at least a year or two for the entire process
to be complete, and depending on the severity of the wound, could take even longer
(Velnar et al., 2009). In the wound-healing process, this phase actually overlaps with
nearly all of the other phases. For the healing to progress properly through remodeling,
there must be control of the degradation of old tissue as well as synthesis of new tissue.
The main agent responsible for the breakdown of the extracellular matrix are matrix
metalloproteinases (MMPs), more specifically for this project MMP-1, and is controlled
by its inhibitor TIMP-1. If degradation is too prolific because of an overabundance of
MMP-1, then the wound may never be able to heal properly. At the same time, if old
tissue is not broken down quickly enough to be replaced with new matrix then the new
site will not be strong enough to withstand potential further injury. Having the
degradation and synthesis in equilibrium is essential for the long-term health of the
wound site. As new extracellular matrix is produced, there is an abundance of collagen
being infused into the new skin being formed, which can almost entirely recreate the
strength of the skin present before the wound. During this remodeling phase the collagen
present is transferred from being an unorganized mass present in the site to an organized
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matrix that interconnects building strength and structure at the wound site. As structures
are created, the underlying tissues shrink and contract closing the site as the healing
continues. This closing happens in direct reaction to the creation of new matrix as scar
tissue is replaced with properly created extracellular matrix and as the blood vessels and
capillaries are extended into the newly created matrix. Over time the wound closes itself
and proper healing is complete.
Because of the complexity of this process, it is difficult to analyze all phases of
the healing process at one time. However, a few biological markers have been identified
that influence all stages of the wound-healing process. Proper wound healing requires
matrix metalloproteinases (MMP-1) and its corresponding inhibitor (TIMP-1) to remain
in proper ratios and be present at appropriate times for the wound to heal in a normal and
sufficient manner. The proportions of these proteins in the wound must be precise and, if
there is too much or too little of one specific factor, the healing process will be hindered
and can directly lead to the wound becoming chronic (Muller et al., 2008). The impact of
these factors directly impacts the success or failure of the wound-healing process.
Wounds that follow this process are known as acute healers and wounds that, for any of a
variety of reasons, do not follow this process are called chronic wounds. There are a
number of issues that could be present to cause a wound to become chronic as well as a
number of treatments and management courses that can be taken. This project looks
specifically at patients who have diabetes as they are much more likely to develop
chronic wounds than the general population. People with diabetes are more likely to
have complications “caused by several intrinsic factors (neuropathy, vascular problems,
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other complicating systemic effects due to diabetes) and extrinsic factors (wound
infection, callus formation, and excessive pressure to the site)” (Falagna, 2005).
To further evaluate the role of MMPs & TIMPs in the healing of chronic wounds,16
separate patients with diabetic foot ulcers who were monitored over a twelve-week period
or until the wound has fully healed (Muller et al., 2008). They measured a variety of
wound proteins over this time, which included MMP-1 and TIMP-1. Cross-sectional
areas of the wound were also measured. To further study the influences on the healing
response, patients were subdivided into two categories – “good” healers and “poor”
healers. A “good” healer is defined to be a patient with at least 82% wound closure at the
4-week point, while a “poor” healer is not. This definition was based on another study
(Sheehan et al., 2003) that looked at four-week healing rates of chronic wounds that
healed within 12 weeks. To further analyze the impact of these factors on the healing
response of the wound, a mathematical model was formulated using the median patient
data of the “good” and “poor” healers (Krishna et al., 2015).
In this model, four distinct state variables are used to describe the healing process
through corresponding differential equations containing a total of twelve parameters.
Specifically, these equations look at the evolution of MMP-1, TIMP-1, extracellular
matrix, and fibroblast cell count which are labeled M, T, E, and 𝑓", respectively, and are
shown below in Equation (1) – (4). There are twelve total parameters, 𝑘$ − 𝑘$$ and the
initial fibroblast parameter, 𝑓& .
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Equation 1-4: Mathematical Model of Wound Healing

All equations are non-dimensionalized through rescaling. Both M and T and their
corresponding data with MMP-1 and TIMP-1 are scaled by an average initial value of
TIMP-1. We use the data of the wound cross-sectional area for the ECM by setting 𝐸 =
HIJK LH
HIJK

, where 𝐴NOP is the largest cross-sectional are for all patients. While there are no

data for f, we scale f by its carrying capacity. While the original work was with median
data (Krishna et al., 2015), all subsequent work (French, 2017; Karimli, 2019; Prassad,
2017; Alotaibi, 2019), including this thesis, is with the individual patient data.
Using multiple computational techniques is the basis for this work. One
technique is called mixed effects modeling. Mixed effects modeling is an analytical tool
useful for the repeated measurement of data with subjects, patients, etc. that have random
effects that deviate from a specified norm. Modern uses for mixed modeling effects can
remedy a variety of issues that analysts have run into in the past including, but not limited
to,
(a) deficiencies in statistical power related to the problems posed by repeated
observations, (b) the lack of a flexible method of dealing with missing data, (c)
disparate methods for treating continuous and categorical responses, as well as (d)
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unprincipled methods of modeling heteroskedasticity and non-spherical error
variance (for either participants or items) (Baayen at al., 2008).

Previously, French (2017) applied the technique of mixed modeling effects to the
parameters present in the model using an exponential function of a sum of two
parameters (Equation 5). The parameter β& is a fixed effect that is the same value for all
13 patients (Three patients were unable to be curve fit due to issues with their data.),
while the random variable,𝛷&,T , is a parameter that measures the variability that occurs for
each of the patients. This technique can be applied to any parameter.

𝑘&,T = 𝑒 (V1 0W1,X ) , 𝑖 = 1, … ,12 , 𝑗 = 1, … , 13

(5)

Equation 5: Mixed Modeling of Parameters (French, 2017)

A second set of techniques is optimal design methods. Optimal Design is a method
that has historically been used to identify optimal sampling times and distributions in
relation to the cost of gathering data in effort to minimize the error of the parameter
estimates. In medicine, where data collection can be both sparse and expensive,
identifying optimal times for collecting data for individual patients is essential.
There are many different optimal design techniques that can be used, many of which
were explored in Banks et al. (2011). These differing methods all work by minimizing a
specific characteristic of the model and data set. For example, the Standard Error (SE)
optimal design minimizes the standard error between the model and the original data.
The determinant (D) optimal-design technique works by minimizing the determinant of
the Fisher Information Matrix (FIM), while the eigenvalue (E) optimal-design technique
8

works by minimizing the minimum eigenvalue of the FIM. The Fisher Information
Matrix measures the information that an observable variable contains regarding an
unknown parameter assuming a known distribution (Frieden, 2004).
This project seeks to combine a series of previously-developed methods to analyze
this mathematical model in wound healing. The techniques of mixed-modeling & optimal
design were previously used separately (French, 2017; Karimli, 2019; Alotaibi, 2019;
Prassad, 2017) and part of this project aims to see how these techniques may work
together to create a better understanding of the model. Using parameters that were
identified through mixed-modeling techniques can be put through the optimization
routines that can then be used to identify specific days that data should be collected for
optimal modeling accuracy.
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MIXED MODELING AND OPTIMAL DESIGN

METHODS
The first step in working with the wound-healing data is to create and implement an
algorithm that would use the model from previous work (Krishna et al., 2015) and adapt
it to a given data set. The first previously-developed method (Prassad, 2017) is mixed
effect modeling and used with the following procedure in Alotaib (2019).

Procedure 1: Mixed Modeling Effects
1. Curve fit the individual patient data using the GlobalSearch algorithm (as outlined
in Krishna et al., 2015).
2. Identify a subset of parameters that are divided into fixed and random effects
using 𝑘& = 𝑘& _O`'aN + 𝑘& /&Pb' for the ith parameter. The subset of parameters
used in this project are 𝑘$ , 𝑘c , 𝑘@ , 𝑎𝑛𝑑 𝑘$$ .
3. Fix the other parameters to values from the curve fits in Step 1.
4. Recurve fit all patients simultaneously to find fixed and random effect values
𝑘$ , 𝑘c , 𝑘@ , 𝑎𝑛𝑑 𝑘$$ for all patients using the GlobalSearch algorithm.
5. Combine the random & fixed effect measurement to obtain a mixed modeling
effect estimate for 𝑘$ , 𝑘c , 𝑘@ , 𝑎𝑛𝑑 𝑘$$ .

The GlobalSearch algorithm in MATLAB was unable to curve fit all parameters
simultaneously for the mixed effects model. A subset of parameters was then used. It
was decided that parameters k1, k5, k8, and k11, which are known as the growth
parameters, would be the ones chosen. This work was completed in Alotaibi (2019) and
the mixed-effect parameter values are given in Table 1, where 𝑘& /&Pb' represents the
random effect for the i-the parameter, and 𝑘& gaNh&`b' = 𝑘& /&Pb' + 𝑘& _O`'aN for the i-the
parameter. 𝑘& gaNh&`b' and the fixed values from the individual curve fits for the
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remaining parameters are used for the rest of this work. The next step is to use the
parameter values to run an optimal-design algorithm that would result in the optimal
times for data collection for each patient. The procedure is as follows:

Procedure 2: Optimal Design Code
1. Define a final time T and the number of optimal time values for collecting data.
2. Choose an initial guess for the optimal time points and define the error tolerance for
the GlobalSearch algorithm.
3. Define an optimal design method.
4. After running the optimal design method, return the time values in both days and
weeks and the least-squares minimum value J.

This process was initially done using an SE optimal-design technique, where the Jmin value represented the Standard Error of the FIM. Likewise, we also used E-optimal
design which requires 𝐽 = min {eig(𝐹𝐼𝑀)} which minimizes the minimum eigenvalue of
the FIM. 𝐹𝐼𝑀 = 𝑋 8 𝑋 where X is a sensitivity matrix containing partial derivatives of the
state variables with respect to the parameters. For the D-optimal design algorithm, 𝐽 =
min {det(𝐹𝐼𝑀)}, which minimizes the determinant of the FIM. Then we compare the
results from each technique to see if one technique is better or worse than the others. This
process outputs four individual graphs, one for each of the state variables in the model,
which shows the original data, the model that was created, and final the optimal design
time points. In addition to the graphs, there is a list of data points that gives the exact
values of the optimal design points. These values are given first in weeks and then in
days; this allows the user to make the best decision possible when collecting data
considering the data collection process may be complicated.
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Table 1: Mixed-Modeled Parameters

Finally, after running each optimal design algorithm with the individual curvefitted parameter values, the optimal design algorithms were run with the parameters given
in Table 1. All told, the optimal design algorithms were run 6 times total: 3 with the
individual curve fits and 3 with the mixed modeling parameters.

12

RESULTS
The first series of numerical experiments in the project was done using the Standard
Error (SE) optimal design technique on the data collected for patients 1-15 (Muller et al.,
2008), excluding patients 10 and 13 because of inconsistent or incomplete data. This
series of data collection times provide a general basis that future results would be
compared to and also give an idea of which patients will be difficult or easy to model
data collection. An example of what ideal data collected can be seen for Patient 14
(Figure 1).

Figure 1: Data Collected for Patient 14 Using SE Optimization on Original Parameter Guesses

The four graphs in Figure 1 represent the four state variables in the mathematical
model. The graphs offer a visual comparison of the original data (small data points) and
the mathematical model (solid line). In addition to the graphs, there is a series of data that
represents the results using the optimization technique (circles). Below the graphs is the
13

J value, which represents the current value of the Standard Error associated with the
model. When using SE optimization, this value is minimized and the final value is
displayed along with the graphs. In the case of Patient 14, the final J value is 8.9902.
Finally, there are two rows of data points that represent the optimal time measurements
for data collection that would have resulted in the best model of the original data. The
first row of data displayed represents these optimal data collection times in week and the
second row are those same collection times in days. The input data includes an initial
guess for the optimal time points of 6 data points that are evenly spread out from week 0
to week 12 and then these points are refined to the final values. For patient 14, it actually
turns out that only 5 times for optimal data collection are needed. There were two groups
that data collected fell into once it was collected. When the parameter values used
represented the data well, there were overall positive results using the optimal design
algorithm. This was the case for patients 2, 3, 4, 5, 6, 7, 11, 12, 14, and 15, but not for 1,
8, and 9.
Next, the mixed modeling parameters (Table 1) were introduced into the optimaldesign program and then the above process was then repeated to observe any changes in
the modeling accuracy and the optimal design data results. This series of computational
runs began to show a problem. While there were certain patients that showed decent
modeling results with the introduction of these new parameters (i.e, Patients 4, 14, 15),
most of the results illustrated issues with the mixed modeling parameters. The main issue
that appeared to be distorting the data was the Fisher Information Matrix (FIM)
approaching or becoming singular. Because the program works by minimizing a value
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associated with the inverse of the FIM this raised a consistency issue. The program
would begin as intended and then somewhere along the line it would fail.
The algorithm was then rerun using D-optimal and E-optimal design for both sets
of parameters. Once again, this series of results fell into two groups. When using D- and
E-optimal design, these two techniques produced similar results. For both optimal-design
techniques patients 1, 2, 4, 5, 6, 7, 12, 14, and 15 displayed accurate fits (like Figure 3),
while patients 3, 8, 9, and 11 did not. However, the high J-value for almost all patients
(Table 3) using D-optimal and E-optimal design suggests all cases had difficulty with the
FIM being singular or near singular. Yet, even with high J values, the algorithm still
seems to produce reasonable results, such as having two time measurements between the
extreme and inflection points of the MMP-1, TIMP-1, and ECM graphs (Figure 2).

Figure 2: Data Collected for Patient 3 Using E Optimization on Original Parameter Guesses
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Parameters
Patient 1

3.954

SE-Optimal
Design,
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93.1693
2.9442
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Patient 5
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2.3674 E 03
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-3.4866 E
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Design,
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Parameters
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Design,
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1.2684 E 70

7.4452 E 14
7.5256 E 08

4.8460 E 19
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-4.6888 E
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1.6645 E 41
1.6315 E 59

3.9520 E 12

1.4439 E 15

1.3005 E 08
9.1881 E 24

7.0634 E 11
1.9220 E 25

7.2603 E 74
-1.6763 E
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1.8611 E 73

1.1613 E 12
7.7328 E 26

3.9419 E 14
4.9932 E 27

4.0195 E 25

3.4141 E 17

2.2910 E 78

9.8501 E 20

2.8563 E 21

-1.0669 E
75
495.7772
3.1674 E 25 2.2224 E 57
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Table 2: J-min Values for Each Patient

2.5829 E 13

4.2474 E 27

8.4847 E 14
7.4692 E 07

2.5079 E 22
2.9750 E 10

5.5534 E 03
288.8716

-1.4192 E
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592.6011

D-Optimal
Design,
Individual
Parameters
-2.9949 E
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33
1.3386 E 05
-3.9193 E
67
2.7343 E 42
-2.421 E
101
-6.6248 E
65
-1.9727 E
70
4.7766 E 66

When comparing SE-optimal design, in which the J-min value is the final
Standard Error value derived from the FIM, individual-parameter to mixed-modeling
parameter results, the J-min value is fair-to-excellent for Patients 1, 2, 3, 5, 6, 14, and 15
for both sets of parameters. Only Patient 7 has a fair J value for the individual
parameters, but not with the mixed-modeling parameters, while 9 and 11 are the opposite.
Patient 4 has an excellent J-value for its mixed-modeling parameters, but not with regard
to individual parameters. Patients 8 and 11 have poor J values with either technique. In
all cases, the SE-optimal design performed better than D- and E-optimal design, which is
consistent with another study (Banks et al., 2011).
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Figure 3: Data Collected for Patient 4 Using D Optimization on Mixed-Modeling Parameters

The high J-values represent a problem that has occurred across all three optimal
design techniques and seems to be an issue for both the individual parameters and the
mixed-modeling parameters as the FIM becomes singular. Because this issue occurs
after several iterations of the algorithms, it seems likely that there is a solution to this
problem which would allow for the collection of relevant data that is not skewed by the
issues currently present.

CONCLUSIONS
The first major conclusion that can be derived from the work is that SE-optimal
design is an excellent tool for the project, especially when compared to the other optimal
design techniques that were utilized in the project. The best indication of this are the J-
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values obtained from using SE-optimal design are much more consistent and reasonable
than the values obtained from the other techniques. In addition, the graphs that were
obtained with these values also tell the same story. For each set of simulations, there
were groups of patients that were identified as good and poor fits by looking at the graphs
that represent each of the 4 state variables and in each case the SE-optimal design
performed as well or better than the other two techniques. All in all, this supports
previous work that had been done in regards to developing and testing SE-optimal design
(Banks et al., 2011). In this study, it was decided that while SE-optimal design is not
always better than more traditional techniques, like D-optimal and E-optimal, it was at
the very least on par and can sometimes lead to better results. Our results support the
previous conclusions. Therefore, any future work will continue with SE-optimal design
as the primary optimal design technique used.
To potentially improve our results, we will work to test and improve the estimates for
mixed-modeling parameters. If the parameters that are being fed into the optimal design
process are poor estimates, this can lead to poor results when using the optimal design
algorithms. To do this, future work will be done exploring MONOLIX, as a possible
mixed-modeling alternative to using MATLAB. It is hoped that this focus can further
improve the results for both optimal design and the mixed modeling areas of the project.
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FORMULATING A NEW MODEL AND MONOLIX TRANSITION

METHODS

MONOLIX is an advanced solver for non-linear mixed effects modeling
(MONOLIX, 2016). It has been recommended by various experts in the field whom we
have talked to as a software tool to analyze our model. MONOLIX is an advanced solver
for non-linear mixed effects modeling. To begin with, we decided to work with a simpler
model to test MONOLIX and see its effectiveness. From there, we would continue to
increase the model complexity until either implementing MONOLIX using our model or
the academic year ended.
First, we decided that the modeling of logistical growth would be a reasonable
starting point. The logistical growth equation is easy to manipulate, has a well-known
solution, and its numerical solution generally resembles the behavior that we expect to
see in the fibroblast equation in our model. We started by creating a pseudo-random data
set from the logistic growth model and take that data and try to fit it to confirm that we
had a data set that would match the original logistic model. If we were able to do this for
a simple version of the function as well as a more complex system of equations we would
be able to easily move this data set, as well as our custom model, over to MONOLIX.

'v
')

= 𝑥 ∗ 𝑌(𝑡) ∗ (1 −

v())
{

)

Equation 6: Basic Logistic Growth Model

19

(6)

Equation (6) is the logistic growth differential equation, where x represents the growth
rate, and w represents the carrying capacity. To create a data set, we took this model and
produced two data sets, which can represent two patients, by adding random “noise” for
integer time points between 0 and 5, inclusive. One data set is generated with a growth
rate of 1.5 and a carrying capacity of 150, while the other with a growth rate of 1 and a
carrying capacity of 100. Table 3 shows these two data sets that were created using the
single ODE with two sets of parameter values.

Solution Data
for Patient 1
PseudoRandom Data
for Patient 1
Solution Data
for Patient 2
PseudoRandom Data
for Patient 2

0

1

2

3

4

5

10

36.3740

88.3903

129.8110

144.9692

148.8474

10

43.0890

76.3154

136.9834

161.2716

153.7364

5

12.5161

28.0005

51.3887

74.1841

88.6508

5

22.8630

35.2693

48.3543

77.1228

80.7780

Table 3: Data for Patients 1 and 2 Created Using Logistic ODE

To test the data, the data was curve fit using MATLAB’s fminseearch, a local
optimization routine, minimizing the sum of squares of the error. When running this
algorithm there are certain values that must be estimated and known. First, the initial
conditions for each patient are input into the algorithm. Then, the algorithm requires an
initial guess estimated for the parameter values. This allows the algorithm to differentiate
potential conflicts between local and global minimum. However, a variety of initial
guess estimates were tested and similar solutions were always obtained. While accurate
initial guesses are likely necessary for a more complex system, for these data sets they
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were not. Overall, this supports the data being an accurate representation of the solutions
to Equation (6) for each patient as the returned parameter values were always close to the
parameters that were used to create the data.
Next, we used the data with a mixed-effects model. This is to confirm that we
have data to use with a mixed-effects model before using. To make this change, we need
six parameters with initial estimates for these parameters. The mixed-effects model is
given in Equations (7) and (8), where Y1 is for Patient 1 and Y2 is for Patient 2.

'v,
')
'v3
')

v ())

= (𝑘$ + 𝑘c ) ∗ 𝑌$ (𝑡) ∗ (1 − (+ ,0+ ))
3

=

v ())

= (𝑘4 + 𝑘c ) ∗ 𝑌| (𝑡) ∗ (1 − (+ 30+ ))
}

=

(7)
(8)

Equations 7-8: Models for Patients 1 and 2

To represent as a mixed-effects model, the carrying capacity and growth rates
have been split into the sum of two parameters giving two new parameters that are then
shared between the two patients. Here, 𝑘$ -𝑘6 are still unique to each patient and
represent the random variables, while 𝑘c and 𝑘~ are shared by each and are thus the fixed
variables for the two patients.
We, then, decided to do a quick numerical study to see the effects of the data
becoming sparse. This was done by only using subsets of the data and then re-curve fit to
see if there was any change in the overall fit of the model. The original data set that used
integer time values from day 0 to day 5 with day 0 being the initial condition. We
comparted this set with data from days 0, 1, 3, and 5 as well as the data from days 0, 2,
and 4.
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Once the data had been properly modeled using one simple ordinary differential
equation (ODE) for each patient, the next step was to create a system of equations for
each patient. This adds complexity to the model and is closer to what our model is for
diabetic ulcer healing. If we are able to correctly model a system of equations for each
patient we should be able to port that system of equations over to MONOLIX as well as
the full diabetic healing model. The system of equations that was decided to work on for
each patient is in Equations (9) and (10).

'v
')
'•
')

= 𝑥 ∗ 𝑌(𝑡) ∗ (1 −

v())
{

)

= 𝑧 ∗ 𝑌(𝑡) ∗ 𝐺(𝑡)

(9)
(10)

Equations 9-10: System of Equations Logistic Growth Model

This system of equations is more complex than the previous model as it
introduces another parameter z, which in this case is an interaction rate that, introduces a
relationship between the first ODE and the second. The second function being a
decaying interaction function is quite important as it closely resembles the biological
interaction relationships that are expected in Equations (1) – (4). In that model,
biological enzymes and their inhibitors interact and compete with one another and this
relationship is best replicated with a decaying interaction ODE as seen in our system. As
before, two sets of parameters were introduced to simulate two separate patients. The
first patient has a growth rate of 1.5, a carrying capacity of 150, and an interaction rate of
.002. The second has a growth rate of 1.0, a carrying capacity of 100, and an interaction
rate of .003. To create a new data set for each of the patient’s data these parameters were
entered into the above ODEs and then solved. Time points where once again intervals of
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1 starting at 0 and ending at 5. This data was collected, and then random noise was once
again added to each data point. While the first data set for each patient is essentially the
same as before the resulting data from the second ODE for each patient can be seen
below.

0

1

2

3

4

5

Solution Data
20
18.7860 15.6346
11.1873
7.3737
4.7390
for Patient 1
Pseudo-Random 20
18.0399 17.2656
12.7851
7.6141
5.8815
Data for Patient
1
Solution Data
40
39.0231 36.8080
32.7163
27.0588
21.1462
for Patient 2
Pseudo-Random 40
38.6131 36.5597
35.6957
29.8769
23.9806
Data for Patient
2
Table 4: Data for Patients 1 and 2 Created by Second ODE in System of Equations

The generated data was then used to refit equations (9) – (10). The same
fminsearch MATLAB function that was used before was modified to model each of the
patients’ data sets separately and then solve for the individual parameters. This function
produced two modeled graphs of the data fit, one for each ODE, as well as three
individual parameters that corresponded to each patients’ x, w, and z values from
Equations (9) and (10). We again conclude that we can determine the model parameter
values well from simulated data.
Next, we consider the system of ODEs using mixed-effects modeling. In this case,
there were nine parameters between the two patients and the ODEs that were used to
model each patient given in equations (11)-(14).
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'v,
')
'•,
')
'v3
')
'•3
')

v ())

= (𝑘$ + 𝑘> ) ∗ 𝑌$ (𝑡) ∗ (1 − (+ ,0+ ))

(11)

= (𝑘4 + 𝑘D ) ∗ 𝑌$ (𝑡) ∗ 𝐺$ (𝑡)

(12)

3

‚

v ())

= (𝑘6 + 𝑘> ) ∗ 𝑌| (𝑡) ∗ (1 − (+ 30+ ))

(13)

= (𝑘~ + 𝑘D ) ∗ 𝑌| (𝑡) ∗ 𝐺| (𝑡)

(14)

9

‚

Equations 11-14: System of Equations Models for Patients 1 and 2

Here, Equations (11) and (12) are for Patient 1 and Equations (13) and (14) are for
Patient 2. As before, each parameter has been split into the sum of two parameters, with
one of those being shared with the other patient. Once again a variety of initial parameter
guesses were used to see if being off on the parameters guess would produce bad results
from fitting. And as before there were no issues found with trying a variety of
parameters guesses; the only thing that it seemed to effect by the various inputs where
how long the program would take to reach a solution. This shows that the parameters in
the model are identifiable and able to be used to create a pseudo-random data set, and that
this data set is able to be modeled back to estimate the original parameter values. This
means that the next step, the transition to MONOLIX, is ready.
When looking at moving this data over to MONOLIX the first place to start is to
use the model library that comes preloaded with the software, specifically the PKPD
model library. PKPD stands for pharmacokinetic/pharmacodynamic modeling, which is
typically used for modeling the intensity of medical pharmaceutical and its relationship to
dosing times and regiment. The models present in the PKPD library cover a variety of
dosing timings, models, and data collection methods. The issue that became apparent
with this was that none of the preloaded models worked in the way that we were hoping
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and we did not figure out how to use MONOLIX for the above work at the time of this
writing. While the originally planned stopping spot for this section of the project was to
complete the transfer of the model to MONOLIX, this was where the work for this
project ended.

RESULTS

First, we generated pseudo-randomized data for each of our imaginary patients.
We solved Equation (6) using pre-selected parameter values at integer time values. Then
we added pseudo-random noise to the numerical solutions at the integer time values to
generate our data. Each of the below results was also replicated using a variety of initial
parameter guesses as well as with multiple replications for each step.
Next, we used this random data to see how well we can re-curve fit both data sets
in MATLAB using the built-in function, fminsearch (MATLAB, 2019) minimizing the
sum of squared differences between the model and the data. Patient 1’s data was created
using parameter values of 1.5 and 150, while Patient 2’s data was created using parameter
values of 1 and 100. Figures 4 and 5 show that that the data was well fit using the
MATLAB routine. In addition to these graphs, the values in Table 5 also show that the
routine is able to identify and estimate the original parameter values that were used to
create the data.
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Figures 4-5: Modeled Data for Patients 1 and 2

Growth Rate
Carrying Capacity
Parameters Used to Create
1.5
150
Patient 1 Data
Parameter Values Returned
1.4035
163.0693
for Patient 1
Parameters Used to Create
1.0
100
Patient 2 Data
Parameter Values Returned
1.1215
86.4586
for Patient 2
Table 5: Parameter Values for Patients 1 and 2

Next, the program was modified for mixed-modeling parameters. To maintain
consistency and to be able to accurately compare results the same data was once again
used. Figures 6 and 7 as well as the data in Table show that we were able to accurately
able to model the data and estimate the original parameter values.
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Figures 6-7: Mixed-Modeling Data for Patients 1 and 2

Parameter
Values Returned
for Patient 1
Parameter
Values Returned
for Patient 2

Growth Rate
(Fixed)

Growth Rate
(Random)
0.0638

Carrying
Capacity
(Fixed)
76.1868

Carrying
Capacity
(Random)
86.8826

1.3397
1.3397

-0.2182

76.1868

10.2718

Table 6: Mixed-Modeling Parameter Values for Patients 1 and 2

Before moving on to the system of equations, the numerical study with fewer data
points brought some interesting results. This study was done to test the effectiveness of
our current technique when looking at data sets that were incomplete or having less and
less data.

Figures 8-9: Mixed-Modeling Data for Patient 1 With Less Data
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Figure 8 shows the model using mixed-modeling parameters with data from days
0, 1, 3, and 5, while Figure 9 shows the model using mixed-modeling parameters with
data from days 0, 2, and 4. Both figures represent data collected for Patient 1, however
the data collected for Patient 2 mirrored the above graphs in both instances. When
comparing these graphs to those generated when using the individual parameters, it can
be seen that these are slightly better. While the data set is quite small, and this is not
surprising as having more parameters allows for a better fit. In addition, the parameter
values that are returned in both of these instances shows that mixed-modeling parameters
allows for accurate finding of the original parameter values even with less data points
(Table 7).

Parameter
Values Returned
for Patient 1
(0135)
Parameter
Values Returned
for Patient 2
(0135)
Parameter
Values Returned
for Patient 1
(024)
Parameter
Values Returned
for Patient 2
(024)

Growth Rate
(Fixed)

Growth Rate
(Random)
0.1417

Carrying
Capacity
(Fixed)
70.0567

Carrying
Capacity
(Random)
82.8408

1.5084

1.5084

-0.4726

70.0567

17.5804

1.1265

0.1399

91.6408

86.7694

1.1265

0.0794

91.6408

-4.3134

Table 7: Mixed-Modeling Parameter Values with Less Data

Next, we formulate a system of equations, which adds a level of complexity and
more closely aligns to model Equations (1) – (4), which is our system of differential
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equations. Rather than modify the first equation, we simply developed a second equation
(Equation (10)), which couples the two equations.
Mirroring the previous work, the next step was to take these data sets and then to
see if they could be modeled to identify the original parameters that were used to create
the data. The previous MATLAB program that was used with the previous data is once
again adapted to model the new system of equations. Because the new model is made up
of two ODEs, the second of which is actually dependent on the solution of the first, this is
a bit more complex. However, the same concept of modeling the data, minimizing the
sum squared difference, and then outputting the model alongside the original data still
stands. The data that was generated for this step can be seen above in Methods.
Next, we re-curve fit all four equations. Again, there is excellent agreement
between the model and generated data (Figures 10-11). The data for Patient 1 was
created using parameter values of 𝑘$ = 1.5, 𝑘| = 150, and 𝑘4 = -0.002, while the data
for Patient 2 was created using parameter values of 𝑘$ = 1, 𝑘| = 100, and 𝑘4 = -0.003.
And since the program returned values of 1.4034, 163.0785, -0.0026, 1.12, 86.5608, and .0022, we can reasonably identify the parameters.
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Figures 10-11: Data Fits for ODE 2 in System of Equations with Individual Parameters

The final addition of complexity to the model before the transition to MONOLIX
was to introduce mixed modeled parameters into this system of equations. Once the
necessary changes to the code were completed, the program was rerun and produced
graphs and values that were remarkably similar to the above graphs.
Growth
Rate
(Fixed)
1.2641

Growth
Rate
(Random)
0.1394

Carrying
Capacity
(Fixed)
113.7930

Carrying
Capacity
(Random)
49.2855

Interaction
Rate
(Fixed)
0.0024

Interaction
Rate
(Random)
0.0002

Parameter
Values
Returned
for Patient
1
Parameter 1.2641
-0.1440
113.7930 -27.2321
0.0024
-0.0002
Values
Returned
for Patient
2
Table 8: Mixed-Modeling Parameter Values for Patients 1 and 2, System of Equations

With the mixed modeling parameters, the final results for parameter values would
nearly always be close to the initial guess, but if the fixed and random values were
combined into a single parameter, that value was consistent across all of the initial
guesses. Specifically, 𝑘$ - 𝑘~ are the random effects that are unique to each patient, and
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𝑘> - 𝑘D are the fixed effects that are shared between the two patients. While the graphs
obtained from modeling the data using the mixed-modeling parameters is nearly identical
to Figure (10) and (11), the parameter values returned, given in Table 8 show us that the
program was accurately able to estimate the parameters used to create the data. The
ability to provide clear and consistent answers across multiple data sets with a variety of
initial guesses tells us that the program is working properly to identify and accurately
predict the parameter values of the data that it is given.
Our results are consistent because the randomized data was reproducible, each set
was representative of the model, and each of the models were done with various initial
parameter guesses. The next step in the project was planned to be to now move this
model over to MONOLIX as a precursor to the diabetic healing model, but we have been
unable to replicate these types of results in MONOLIX at the time of this defense. If we
obtained reliable results using equations (1) – (4) in MONOLIX, we would then re-run
the SE-optimal design algorithm with the mixed-modeling parameters.

CONCLUSIONS
While the major goal, transitioning the new model into MONOLIX, of this
section of the project was unsuccessful because of technical, as well as situational, issues
there are still quite a few of results from the work done that allow for some general
conclusions. First, the model was able to be accurately solved and modeled using the
tools available in MATLAB. In addition is was shown that an interconnected system of
ordinary differential equations was able to be modeled and analyzed properly, which
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points to the long-term viability of the full model. Finally, the small look at using various
sizes of data sets was interesting as it showed that as less data was available the better
mixed modeled parameters performed. Overall, this part of the project will serve as an
excellent starting point for future work on an introduction of using tools like MONOLIX.
The next step for this project is to continue to work on integrating the current
model into the MONOLIX software. With MONLIX’s ability to identify and work easily
with mixed-modeling parameters new and better estimates for the values may be found
which can in turn improve the optimal design work with Equations (1) – (4). While this
step has not been completed at the time of this defense, the work to accomplish this move
has continued.
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